Medicare Enrolled
Dr. Sreenivasa Chanamolu, M.D,
Pulmonary Disease · Lima, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chanamolu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chanamolu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chanamolu
Dr. Sreenivasa Chanamolu is a pulmonary disease specialist in Lima, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chanamolu performed 2,467 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chanamolu received a total of $9,083 from 49 pharmaceutical and/or device companies across 566 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chanamolu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 5% volume in OH
$9,083 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,467
Medicare services
Top 5% in OH for pulmonary disease
Not available
Unique patients (not deduplicated)
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
565 | $61 | $104 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
259 | $90 | $149 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
244 | $87 | $191 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
243 | $85 | $264 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
169 | $128 | $291 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
158 | $94 | $280 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
132 | $8 | $22 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
109 | $7 | $15 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
106 | $161 | $320 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
99 | $9 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $104 | $247 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $95 | $198 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
58 | $58 | $134 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $123 | $267 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
36 | $32 | $108 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
24 | $27 | $85 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
22 | $77 | $241 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
22 | $24 | $53 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
16 | $186 | $1,366 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,083
Total received (2018-2024)
Avg $1,298/year across 7 years
Top 18% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
566
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$256
2023
$1,130
2022
$1,461
2021
$1,622
2020
$1,545
2019
$1,325
2018
$1,744
Payments by company (2024)
Inspire Medical Systems, Inc.
$94
GlaxoSmithKline, LLC.
$29
ZOLL Respicardia, Inc.
$26
INOGEN, INC.
$23
Amgen Inc.
$18
Grifols USA, LLC
$18
Insmed, Inc.
$17
Axsome Therapeutics, Inc.
$16
Electromed, Inc.
$15
Top 3 companies account for 58.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,464
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,335
GlaxoSmithKline, LLC.
$1,177
Actelion Pharmaceuticals US, Inc.
$598
Jazz Pharmaceuticals Inc.
$367
Genentech USA, Inc.
$322
JAZZ PHARMACEUTICALS INC.
$311
Sunovion Pharmaceuticals Inc.
$248
Inspire Medical Systems, Inc.
$208
Takeda Pharmaceuticals U.S.A., Inc.
$207
GENZYME CORPORATION
$179
Astellas Pharma US Inc
$173
Regeneron Healthcare Solutions, Inc.
$165
Janssen Pharmaceuticals, Inc
$146
United Therapeutics Corporation
$146
Bayer HealthCare Pharmaceuticals Inc.
$144
Grifols USA, LLC
$143
Philips Electronics North America Corporation
$132
Mallinckrodt Hospital Products Inc.
$121
Covidien LP
$116
Mylan Specialty L.P.
$115
Amgen Inc.
$107
PFIZER INC.
$107
Pulmonx Corporation
$106
Electromed, Inc.
$94
Baxter Healthcare
$77
Harmony Biosciences LLC
$77
Teva Pharmaceuticals USA, Inc.
$71
Circassia Pharmaceuticals Inc
$70
Advanced Respiratory, Inc
$60
Insmed, Inc.
$50
Shire North American Group Inc
$47
Mallinckrodt Enterprises LLC
$45
Merck Sharp & Dohme Corporation
$32
Apria Healthcare LLC
$32
Axsome Therapeutics, Inc.
$31
Phadia US Inc.
$29
Resmed Corp
$28
ZOLL Respicardia, Inc.
$26
INOGEN, INC.
$23
AbbVie Inc.
$23
Inogen, Inc.
$22
Covis Pharma GmBH
$18
HARMONY BIOSCIENCES LLC
$18
E.R. Squibb & Sons, L.L.C.
$17
Vapotherm Inc
$17
ABBVIE INC.
$16
Eisai Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 43.8% of all-time payments
Associated products mentioned in payments ›
(2547) Sleep Other · (2791) CoughAssist · (8874) inCourage · ACTHAR · AIRSENSE · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · CRESEMBA · Cresemba · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 205 Acute Care · Hillrom - Volara System · Horizant · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · LONHALA MAGNAIR · Life 2000 Ventilation System · MYCAMINE · Medela · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · Perforomist · Precision Flow · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · SuperDimension · TAGRISSO · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Utibron · Wakix · Wellcentive Undiv · XARELTO · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
3
County median income
$62,001
Nearest hospital to ZIP centroid (approximate)
MERCY HEALTH-ST RITA'S MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chanamolu is a clinical cardiology specialist, with above-average Medicare volume (top 5% in OH), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chanamolu experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Chanamolu performed 565 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chanamolu receive payments from pharmaceutical companies?
Yes. Dr. Chanamolu received a total of $9,083 from 49 companies across 566 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chanamolu's costs compare to other pulmonary diseases in Lima?
Dr. Chanamolu's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chanamolu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Lima
Browse pulmonary diseases in Lima ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in OH
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in OH
Which OH pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology